... . Can also be used for female functional uterine bleeding, climacteric syndrome, breast cancer and genital cancer; liver cirrhosis, aplastic anemia, osteoporosis ...
... . Can also be used for female functional uterine bleeding, climacteric syndrome, breast cancer and genital cancer; liver cirrhosis, aplastic anemia, osteoporosis ...
... progestogenic activity. A pharamceutical used in the treatment of menopausal syndrome. Applications: pharmaceutical material, Steroid hormone, Anabolin. A synthetic steroid with ...
... progestogenic activity. A pharamceutical used in the treatment of menopausal syndrome. Description: Tibolone (Livial/Liviella) is used mainly for treatment of ...
... : For none of testosterone replacement therapy, treatment of male climacteric syndrome, impotence. B. Sports use: To increase the amount of muscle ...
... : For none of testosterone replacement therapy, treatment of male climacteric syndrome, impotence. B. Sports use: To increase the amount of muscle ...
... . Can also be used for female functional uterine bleeding, climacteric syndrome, breast cancer and genital cancer; Liver cirrhosis, aplastic anemia, osteoporosis ...
[email protected] skype:qiuxin199374 CAS: 5630-53-5 EINECS: 227-069-1 Assay: 99% min. Packing: 1kg/foil bag. Delivery: Express courier. MF: C21H28O2 MW: 312.45 Character: White powder. MP: 169. Usage: pharmaceutical material, Steroid hormone, Anabolin. A synthetic steroid with weak estrogenic, androgenic and progestogenic activity. A pharamceutical used in the treatment of menopausal syndrome.
... reverse metabolic abnormalities in obese men with pre-diabetic metabolic syndrome, most likely by stimulating fatty acid oxidation. It has been ...
... normal function, for disease-free testosterone replacement therapy, male menopause syndrome, impotence and other diseases Treatment, but also for women of ...
Hot Products: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9
Copyright Notice @ 2008-2022 ECBAY Limited and/or its subsidiaries and licensors. All rights reserved.